It is now 3 1/2 years since our petition and lawsuit against FDA forced
Sandoz to delist bromocriptine's use for lactation suppression in the U.S.
and Canada. Since then, this has occurred in other countries as well but
there are still many countries in which this has not occurred. Could e-drug
subscribers please send to my e-mail address---swolfe@citizen.org, the
current status in your country of bromocriptine for lactation suppression
and when, if such is the case, the delisting for this indication occurred.
If you have specific references to published articles documenting this it
would be helpful but not necessary.
Thank you in advance
Sid Wolfe
Public Citizen's Health Research Group
1600 20th st NW, Washington, DC 20009
fax 202 588-7796
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.